参考文献/References:
[1] Mitsuuchi Y, Johnson SW, Sonoda G,et al. Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2[J].Oncogene,1999,18(35):4891-4898. DOI:10.1038/sj.onc.1203080.
[2] Cheng KK, Lam KS, Wang Y,et al. Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells[J].Diabetes,2007,56(5):1387-1394. DOI:10.2337/db06-1580.
[3] Schmid PM, Resch M, Steege A,et al. Globular and full-length adiponectin induce NO-dependent vasodilation in resistance arteries of Zucker lean but not Zucker diabetic fatty rats[J].Am J Hypertens,2011,24(3):270-277. DOI:10.1038/ajh.2010.239.
[4] Marinho R, Ropelle ER, Cintra DE,et al. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss[J].J Cell Physiol,2012,227(7):2917-2926. DOI:10.1002/jcp.23037.
[5] Cheng KK, Lam KS, Wu D,et al. APPL1 potentiates insulin secretion in pancreatic β cells by enhancing protein kinase Akt-dependent expression of SNARE proteins in mice[J].Proc Natl Acad Sci U S A,2012,109(23):8919-8924. DOI:10.1073/pnas.1202435109.
[6] Mao X, Kikani CK, Riojas RA,et al. APPL1 binds to adiponectin receptors and mediates adiponectin signalling andfunction[J].Nat Cell Biol,2006,8(5):516-523. DOI:10.1038/ncb1404.
[7] Yamauchi T, Kamon J, Ito Y,et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects[J].Nature,2003,423(6941):762-769. DOI:10.1038/nature01705.
[8] Deepa SS, Zhou L, Ryu J,et al. APPL1 mediates adiponectin-induced LKB1 cytosolic localization through the PP2A-PKCzeta signaling pathway[J].Mol Endocrinol,2011,25(10):1773-1785. DOI:10.1210/me.2011-0082.
[9] Chandrasekar B, Boylston WH, Venkatachalam K,et al. Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase(AMPK)activation and IKK/NF-kappaB/PTEN suppression[J].J Biol Chem,2008,283(36):24889-24898. DOI:10.1074/jbc.M804236200.
[10] Tian L, Luo N, Zhu X,et al. Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses[J].Atherosclerosis,2012,221(1):66-75. DOI:10.1016/j.atherosclerosis.2011.12.014.
[11] Xin X, Zhou L, Reyes CM,et al. APPL1 mediates adiponectin-stimulated p38 MAPK activation by scaffolding the TAK1-MKK3-p38 MAPK pathway[J].Am J Physiol Endocrinol Metab,2011,300(1):E103-E110. DOI:10.1152/ajpendo.00427.2010.
[12] Ding Y, Zhang D, Wang B,et al. APPL1-mediated activation of STAT3 contributes to inhibitory effect of adiponectin on hepatic gluconeogenesis[J].Mol Cell Endocrinol,2016,433:12-19. DOI: 10.1016/j.mce.2016.05.021.
[13] Yamaguchi N, Kukita T, Li YJ,et al. Adiponectin inhibits induction of TNF-alpha/RANKL-stimulated NFATc1 via the AMPK signaling[J].FEBS Lett,2008,582(3):451-456. DOI:10.1016/j.febslet.2007.12.037.
[14] Jiang ZY, Zhou QL, Coleman KA,et al. Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing[J].Proc Natl Acad Sci U S A,2003,100(13):7569-7574. DOI:10.1073/pnas.1332633100.
[15] Saito T, Jones CC, Huang S,et al. The interaction of Akt with APPL1 is required for insulin-stimulated Glut4 translocation[J].J Biol Chem,2007,282(44):32280-32287.
[16] Deepa SS, Dong LQ. APPL1: role in adiponectin signaling and beyond[J]. Am J Physiol Endocrinol Metab, 2009, 296(1):E22-E36.DOI:10.1152/ajpendo.90731.2008.
[17] Wang Y, Cheng KK, Lam KS,et al. APPL1 counteracts obesity-induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothelin-1 in mice[J].Diabetes,2011,60(11):3044-3054. DOI:10.2337/db11-0666.
[18] Ryu J, Galan AK, Xin X,et al. APPL1 potentiates insulin sensitivity by facilitating the binding of IRS1/2 to the insulin receptor[J].Cell Rep,2014,7(4):1227-1238. DOI:10.1016/j.celrep.2014.04.006.
[19] Du K, Herzig S, Kulkarni RN,et al. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver[J].Science,2003,300(5625):1574-1577. DOI:10.1126/science.1079817.
[20] 徐淼,肖元元,韩峻峰.APPL1介导瘦素对C2C12细胞GSK-3β活性的影响[J].中华医学杂志,2013,93(18):1432-1436. DOI:10.3760/cma.j.issn.0376-2491.2013.18.016.
[21] Cheng KK, Lam KS, Wang Y,et al. TRAF6-mediated ubiquitination of APPL1 enhances hepatic actions of insulin by promoting the membrane translocation of Akt[J].Biochem J,2013,455(2):207-216. DOI: 10.1042/BJ20130760.
[22] Leibiger IB, Leibiger B, Berggren PO. Insulin signaling in the pancreatic beta-cell[J].Annu Rev Nutr,2008,28:233-251. DOI: 10.1146/annurev.nutr.28.061807.155530.
[23] Wang C, Li X, Mu K,et al. Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function[J].Diabetologia,2013,56(9):1999-2009. DOI:10.1007/s00125-013-2971-4.
[24] Holmes RM, Yi Z, De Filippis E,et al. Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif(APPL1)in patients with obesity and type 2 diabetes: evidence for altered adiponectin signalling[J].Diabetologia,2011,54(8):2122-2131. DOI: 10.1007/s00125-011-2173-x.
[25] 王玉环,张敏,闫丽丽. AppL1与新诊断2型糖尿病的相关性[J].南方医科大学学报,2012,32(9):1373-1376.DOI:10.3969/j.issn.1673-4254.2012.09.037.
[26] Schmid PM, Resch M, Schach C,et al. Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats[J].Cardiovasc Diabetol,2013,12:46. DOI:10.1186/1475-2840-12-46.
[27] Prudente S, Jungtrakoon P, Marucci A,et al. Loss-of-function mutations in APPL1 in familial diabetes mellitus[J].Am J Hum Genet,2015,97(1):177-185. DOI:10.1016/j.ajhg.2015.05.011.
[28] Xing W, Yan W, Liu P, et al. A novel mechanism for vascular insulin resistance in normotensive young SHRs: hypoadiponectinemia and resultant APPL1 downregulation[J].Hypertension,2013,61(5):1028-1035. DOI:10.1161/HYPERTENSIONAHA.111.00728.
[29] Fang X, Palanivel R, Cresser J,et al. An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart[J].Am J Physiol Endocrinol Metab,2010,299(5):E721-E729.DOI:10.1152/ajpendo.00086.2010.
[30] Park M, Youn B, Zheng XL,et al. Globular adiponectin, acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosis[J].PLoS One,2011,6(4):e19143. DOI:10.1371/journal.pone.0019143.
[31] Palanivel R, Ganguly R, Turdi S,et al. Adiponectin stimulates Rho-mediated actin cytoskeleton remodeling and glucose uptake via APPL1 in primary cardiomyocytes[J].Metabolism,2014,63(10):1363-1373. DOI: 10.1016/j.metabol.2014.07.005.
[32] Park M, Wu D, Park T,et al. APPL1 transgenic mice are protected from high-fat diet-induced cardiac dysfunction[J].Am J Physiol Endocrinol Metab,2013,305(7):E795-E804. DOI: 10.1152/ajpendo.00257.2013.
[33] Cao T, Gao Z, Gu L,et al. AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin Ⅱ-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts[J].PLoS One,2014,9(8):e103793. DOI: 10.1371/journal.pone.0103793.
[34] Dadson K, Chasiotis H, Wannaiampikul S,et al. Adiponectin mediated APPL1-AMPK signaling induces cell migration, MMP activation, and collagen remodeling in cardiac fibroblasts[J].J Cell Biochem,2014,115(4):785-793. DOI: 10.1002/jcb.24722.
[35] Ma XW, Ding S, Ma XD,et al. Genetic variability in adapter proteins with APPL1/2 is associated with the risk of coronary artery disease in type 2 diabetes mellitus in Chinese Han population[J].Chin Med J(Engl), 2011,124(22):3618-3621.
[36] Ji Z, Hu Z, Xu Y. APPL1 acts as a protective factor against podocytes injury in high glucose environment[J].Int J Clin Exp Pathol,2015,8(6):6764-6771.